What OmniScience does

OmniScience, Inc. is a Houston, Texas-based AI platform company that builds and sells Vivo, an agentic AI-powered control tower for clinical development, to pharmaceutical sponsors, biotechnology companies, contract research organizations (CROs), and digital health and medical device firms. Founded in 2017 as a clinical data science consultancy originally operating under the name Mercury Data Science, the company rebranded to OmniScience in 2024 and pivoted from services to a product-led platform strategy with Vivo as its flagship offering. The stated footprint is 11–50 employees, a Houston headquarters in the Texas Medical Center Innovation district, and stated engagement with more than 50 life sciences organizations across hundreds of trials spanning Phases 1, 2, 3, and OLE in oncology, CNS, rare disease, and immunology.

Vivo is structured as a five-layer clinical trial intelligence architecture: (L1) Data Sources including EDC, CTMS, TMF, safety databases, labs, imaging, eCOA, IRT, wearables, biomarkers, omics, and vendor files; (L2) a unified, harmonized, governed, AI-ready, role-aware clinical trial data layer; (L3) an agentic reasoning layer that is protocol-aware, source-backed, explainable, role-aware, and blinding-enforced; (L4) a monitoring and evidence layer delivering AI-RBQM risk signals, issue tracking, and evidence packages; and (L5) an action layer that exposes Trial Home, Ask Vivo, workflow tools, APIs, and portfolio views. The architecture is read-only against source systems to preserve data integrity, and the platform is ISO 27001 and ISO 9001 certified, GDPR and HIPAA compliant, GxP-aligned, and built to FDA Part 11/Annex 11 and CSA guidance. The product surface includes Clinical Operations, Data Management and Biometrics, Safety and Medical Monitoring, Portfolio Leadership, CRO/FSP Partners, and Enterprise AI modules; AI capabilities span natural-language querying, multimodal data fusion (text, video, audio, structured, biosensor), anomaly detection, predictive analytics, and computer vision, with one licensed downstream application (tScreen by futuresTHRIVE) using Vivo for pediatric mental health screening.

OmniScience monetizes Vivo primarily through fixed annual enterprise subscription licenses covering all users within a study, with onboarding costs scaled to study complexity (duration, endpoints, data sources, geography) and portfolio-based pricing for multi-study deployments. Go-to-market combines direct enterprise field sales, event-driven demand generation at SCOPE, CNS Summit, DPHARM Idol Disrupt, and Innovation Network Gathering, and channel-led distribution through integration partnerships with Veeva (CTMS/TMF), Medidata (EDC), LabConnect (LIMS), TransCelerate BioPharma (membership), and developer/AI programs at NVIDIA Inception and Google Cloud AI Startups. The company highlights quantifiable outcomes including a 25% acceleration of database lock timelines, a 60–70% reduction in manual tasks, and most teams going live in 6–8 weeks; revenue figures, funding history beyond Mercury Fund incubation, and detailed customer counts are not publicly disclosed.

Name

OmniScience

Legal name

OmniScience, Inc.

Website

https://omniscience.bio

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

OmniScience provides Vivo, an agentic AI-powered control tower for clinical development that unifies fragmented trial data sources and delivers real-time, source-backed, role-aware insights to pharmaceutical sponsors, biotech companies, CROs, and digital health firms.

Ownership category

akta.pro rank

Product category

Clinical Trial Intelligence Software

NAICS

Software Publishers (5132), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)

akta.pro secondary industry

Site Quality Management & Audit Readiness (HLAGACAN)

Keywords

• Clinical trial intelligence
• AI clinical trials
• Risk-based monitoring
• Clinical data platform
• Pharma AI software

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Vivo Platform Subscription: Fixed annual license for Vivo platform access. Covers all users, hosting, maintenance, upgrades, and support. Onboarding costs based on study complexity (duration, endpoints, data sources, geography). Portfolio-based quotes available for multi-study deployments.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

OmniScience sells Vivo, an agentic AI-powered control tower for clinical development that unifies fragmented clinical, safety, and operational data from EDC, CTMS, labs, imaging, eCOA, IRT, wearables, and vendor files into a single governed layer. The platform delivers real-time, source-backed answers (Ask Vivo), continuous AI-RBQM risk monitoring, live operational dashboards (Trial Home), and cross-study portfolio intelligence. It is sold to pharmaceutical sponsors, biotech companies, CROs, and digital health organizations under a fixed annual subscription license.

Product overview

OmniScience offers Vivo, a unified platform-plus-modules architecture for clinical trial intelligence. The core product is Vivo, an agentic AI-powered control tower built on a five-layer architecture that connects to clinical trial data sources, harmonizes them into a unified governed layer, applies agentic reasoning, monitors continuously for risks, and surfaces insights through multiple interfaces. Key interfaces include Ask Vivo (conversational AI for plain-language querying), Trial Home (live operational dashboard), AI-RBQM (continuous risk monitoring), and Portfolio Intelligence (cross-study visibility). These are available as integrated modules for Clinical Operations, Data Management & Biometrics, Safety & Medical Monitoring, CRO/FSP Partners, and Enterprise AI. Additionally, OmniScience's technology powers licensed applications such as tScreen for pediatric mental health screening.

Differentiator

Problem solved

Functional benefit

Brands

• Vivo: AI Control Tower for Clinical Development - the first agentic AI-powered control tower purpose-built for clinical trials, providing real-time, explainable insights by unifying clinical, safety, and operational data.

Products and services

• Vivo Platform Vivo is an agentic AI-powered control tower for clinical development that unifies fragmented clinical, safety, and operational data from EDC, CTMS, labs, safety, imaging, eCOA, IRT, wearables, biomarkers, omics, and vendor files into a single governed, AI-ready data layer. It delivers real-time, source-backed answers, continuous AI-RBQM risk monitoring, and cross-study portfolio intelligence for pharmaceutical sponsors, biotech companies, CROs, and digital health organizations.
• Vivo Clinical Operations Solution A Vivo module for clinical operations teams managing active trials, providing earlier visibility into enrollment, site and vendor monitoring, fewer manual reports, and live operational status across studies.
• Vivo Data Management & Biometrics Solution A Vivo module for data managers and biometrics teams to find data issues earlier, prove readiness with traceable evidence, and progress from discrepancy through query, sign-off, to lock readiness with accelerated database lock.
• Vivo Safety & Medical Monitoring Solution A Vivo module for safety and medical monitoring teams to review safety signals in clinical context, connecting AEs, labs, conmeds, dose, and subject patterns with source-backed evidence for medical review.
• Vivo CRO & FSP Partners Solution A Vivo module giving sponsors transparency and CROs/FSP partners a shared evidence layer for delivery accountability and quality oversight across concurrent programs.
• Vivo Portfolio Intelligence Vivo Portfolio Intelligence provides cross-study visibility into risks, sites, vendors, enrollment, data quality, and executive priorities from one trial to an entire portfolio, with Portfolio Ask Vivo enabling source-backed questions across studies.
• Vivo Enterprise AI Solution A Vivo module for powering internal copilots, analytics workbenches, and agent ecosystems with governed, protocol-aware clinical trial intelligence, with API and headless deployment patterns for enterprise AI integration.
• tScreen (licensed Vivo-powered application) tScreen is a licensed pediatric mental health screening application developed by futuresTHRIVE that leverages Vivo's voice and video analytics to monitor emotional state, language use, and mental health indicators in children aged 5-9, showing 87% agreement with PSC gold standard.

Quantifiable outcome

• Database lock timelines accelerated by 25%
• +3 more outcomes

Named customers15 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability13 records

Feature6 records

Partnerships

Twelve partnerships are on record, tiered core and major.

• TransCelerate BioPharmacoreStrategic or Co-development Partner · 27 May 2026Solution Collaboration Forum Member - joins global network of biopharma leaders, technology innovators, health authorities, and research organizations transforming clinical development. Contributes expertise in agentic AI, real-time clinical trial intelligence, and unified data infrastructure.
• LabConnectcoreTechnology or Integration · 15 September 2025LIMS Integration Partner - first agentic AI solution for real-time clinical trial lab insights. LabConnect provides clinical lab services; Vivo unifies lab data with other trial data sources for real-time insights.
• Integro TheranosticscoreStrategic or Co-development Partner · 12 February 2025Collaboration to improve cancer clinical study outcomes through enhanced image analysis and streamlined trial operations. Focus on breast and lung cancers initially, with expansion planned. Integro's fluorescent imaging agent for surgical visualization combined with OmniScience's AI-powered trial intelligence.
• INmune BiocoreStrategic or Co-development Partner · 4 December 2024Partnership to accelerate INmune Bio's global Phase 2 Alzheimer's trial (AD02) using Vivo. Trial enrolled 208 patients (56% mild AD, 44% MCI). Vivo provides real-time analysis of cognitive results, identifies data discrepancies, and enables faster decision-making. INmune Bio provides continuous feedback that enables Vivo's product roadmap evolution.
• futuresTHRIVEcoreOEM/ Whitelabel/ Licensing Partner · 11 November 2024futuresTHRIVE licensed Vivo for tScreen product - pediatric mental health screening for children aged 5-9. NSF-funded research collaboration since June 2022. Vivo's voice/video analytics capabilities analyze children's emotional state and language use for mental health assessment. tScreen showed 87% agreement with PSC gold standard.
• DiMe (Digital Medicine Society)coreStrategic or Co-development Partner · 6 June 2024Strategic partnership to advance digital endpoints in clinical trials. Contributes to DiMe's 'Building the Business Case for Digital Endpoints' initiative including industry benchmarking tools, ROI forecasting models, and business case templates. OmniScience provides AI platforms (Vivo, Ergo) for digital measure integration.
• Janssen (Johnson & Johnson)majorStrategic or Co-development Partner · 1 February 2022Collaborative work with Janssen Neuroscience team at ACNP Annual Meeting. Published poster abstracts on clinical subtypes and digital biomarker-based stratification in autism using EEG, ECG, and biosensors. Collaboration informed future clinical trial study designs.
• NVIDIAmajorTechnology or IntegrationNVIDIA Inception Program Member - AI innovation ecosystem providing technical enablement, GPU resources, and credibility for AI-powered clinical trial solutions.
• Google CloudmajorTechnology or IntegrationGoogle Cloud AI Startups Program member - access to Google's global network to scale Vivo platform and reshape clinical development.
• Johnson & Johnson JLABSmajorTechnology or IntegrationMember of Johnson & Johnson JLABS Incubator - early-stage innovation partnership providing access to J&J's ecosystem and validation for startups in the healthcare/life sciences space.
• VeevacoreTechnology or IntegrationIntegration with Veeva CTMS and TMF - delivering agentic AI insights across clinical trials. Vivo powers unified trial intelligence across Veeva's clinical trial management ecosystem.
• MedidatamajorTechnology or IntegrationMedidata Developer Central Member - EDC integration partnership enabling Vivo to connect with Medidata's electronic data capture systems.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Veeva Systems: Veeva provides CTMS, TMF, eTMF, and the broader Vault clinical suite; it is an OmniScience integration partner but also a deep incumbent in trial management technology whose roadmap could expand toward agentic AI.
• IQVIA: IQVIA is the largest CRO and life sciences technology vendor, with deep enterprise data and analytics assets. Its scale, installed base, and EDC/CTMS footprint make it the dominant broad incumbent competing for sponsor-level AI clinical intelligence spend.
• Medidata Solutions: Medidata is the leading EDC and clinical trial data platform (Rave) used by most large pharma sponsors. It is also an OmniScience integration partner (Medidata Developer Central), but its broader Rave, imaging, and AI ambitions overlap with the control tower value proposition.
• Oracle Health Sciences: Oracle Health Sciences (formerly Phase Forward / InForm) provides EDC, CTMS, safety, and analytics for clinical development. Its broad clinical portfolio competes for the same sponsor budgets as OmniScience's unified clinical data layer.

Direct peers

• Castor: Castor is a clinical trial data capture and eCRF platform with growing AI capabilities for trial operations. Its eCRF + integrations footprint competes with Vivo's data management and trial oversight modules for mid-size sponsor accounts.
• CluePoints: CluePoints is the established leader in Risk-Based Quality Management (RBQM) and centralized statistical monitoring for clinical trials. OmniScience's AI-RBQM directly overlaps with CluePoints' core risk-based monitoring franchise.
• Saama Technologies: Saama applies AI/ML to unify clinical, safety, and operational data for life sciences sponsors. It is the closest direct competitor to Vivo's agentic, unified-data layer for clinical development across pharma and biotech.
• Cytel: Cytel provides statistical programming, biostatistics, and clinical analytics software (including Solara) for clinical trial data. Its data-management and statistical programming capabilities overlap with OmniScience's Data Management & Biometrics module.
• THREAD: THREAD provides a decentralized clinical trial technology platform supporting eCOA, telehealth, and digital health data capture. It overlaps with OmniScience on multimodal (DHT, video, sensor) clinical trial intelligence use cases.
• YPrime: YPrime offers eCOA, IRT, and clinical technology platforms used by pharma sponsors and CROs. It shares the trial-data integration and oversight category where OmniScience's unified data layer competes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OmniScience